With box warnings

Without box warnings

Branded

Generic

3 results

gemtesa
(vibegron)
Sumitomo Pharma America, Inc.
Usage: GEMTESA® is indicated for the treatment of overactive bladder (OAB) in adults, characterized by urge urinary incontinence, urgency, and urinary frequency. It is also indicated for adult males with OAB symptoms who are undergoing pharmacological therapy for benign prostatic hyperplasia (BPH).
mirabegron
(mirabegron)
Lupin Pharmaceuticals, Inc.
Usage: Mirabegron extended-release tablets are indicated for the treatment of adult overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency. Pediatric use is noted but not included in the labeling due to marketing exclusivity rights.
myrbetriq
(mirabegron)
Astellas Pharma US, Inc.
Usage: MYRBETRIQ is indicated for treating adult overactive bladder (OAB) symptoms, including urge urinary incontinence, urgency, and urinary frequency, either alone or with solifenacin succinate. It is also indicated for pediatric patients (ages 3+) with neurogenic detrusor overactivity (NDO) who weigh 35 kg or more.

beta3-Adrenergic Agonist class drugs

gemtesa